Dec 19 2009
Incheon Free Economic Zone (IFEZ), GE Healthcare and Bio Research 
      Complex (BRC) announced today the signing of a five year plan to invest 
      in the establishment of the “GE Global Ubiquitous Health Research and 
      Development Center” (GE Global u-Health R&D Center).
    
    
      Under the agreement with IFEZ, GE Healthcare, a global leader in 
      transformational medical technologies and services, and BRC, a respected 
      provider of gene analysis technology, will use the facility for research 
      and development activities related to healthcare IT solutions.
    
    
      “The agreement is a perfect example of a collaboration between the 
      Korean government, a local company like BRC and a global company like 
      GE,” said Sang-soo Ahn, the mayor of the Incheon Metropolitan City in 
      which IFEZ is located. “The establishment of the GE Global u-Health R&D 
      Center will be a triggering event in the expansion of IFEZ’s IT and 
      healthcare infrastructure and the buildup of a research network. We’re 
      hoping IFEZ can position itself as the world’s premier project site that 
      best realizes ubiquitous-Health programs, going forward,” added Ahn.
    
    
      Healthymagination is GE’s $6 billion commitment to improve health care 
      access, affordability and quality through advanced technologies, 
      research and development.
    
    
      The Korean government and IFEZ see the establishment of the center as an 
      opportunity to gain advanced clinical knowledge, build professional 
      skills and create jobs through healthcare IT, which is a mainstream 
      green industry. Also, the facilitation of convergence between healthcare 
      technologies and related industries will contribute to the advancement 
      of the domestic IT industry.
    
    
      Vishal Wanchoo, president and CEO of GE Healthcare IT commented, “The 
      Korean government’s active support and collaboration in u-health related 
      research and development played heavily into our decision to 
      participate. We’re excited about the possibilities ahead.”
    
    
      “Our healthcare IT technology and products will play a pivotal role in 
      driving our healthymagination vision,” said Karim Karti, president and 
      CEO of GE Healthcare Korea. “We also hope this collaboration can help 
      advance Korea’s healthcare IT industry, acting as a catalyst for 
      professional relationships and job creation.”
    
    
      “The combination of our achievement in the analysis of Korean gene 
      information and state-of-the-art healthcare IT solutions could lead to 
      personalized healthcare service that reflects an individual’s genetic 
      makeup,” said Uhn Lee, President of BRC. “When an individual’s gene and 
      disease information is used as part of his or her health management,” 
      Lee added, “it could someday lead to accurate diagnosis and effective 
      treatment even before the actual onset of a disease.”
    
    
      In 2007, GE Healthcare established its first Asia EHR (electronic health 
      records) R&D Center in Korea. It is envisioned that its skilled 
      researchers, clinical expertise and technology will become a part of the 
      research and operation of the GE Global u-Health R&D Center.
    
http://www.gehealthcare.com/